Home  |  Archive  |  AJA @ Nature  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

Hyperlipidemia and erectile dysfunction

Sae-Chul Kim

Department of Urology, College of Medicine, Chung-Ang University, Seoul, Korea

Asian J Androl  2000 Sep; 2: 161-166


Keywords: hypercholesterolemia; hypertriglyceridemia;  LDL lipoproteins; HDL lipoproteins; superoxide radicals; NO synthase; cavernous smooth muscle; erectile dysfunction
Abstract
We have done consecutive studies to investigate the effects of impaired lipid metabolism on the contractile and relaxation response of cavernous smooth muscles and to elucidate its pathogenesis: 1) incidence of hyperlipidemia in impotent patients; 2) erection response to intracavernous injection of papaverine in impotent patients with hyperlipidemia; 3) relaxation responses of isolated cavernosal smooth muscles to endothelium-independent and endothelium-dependent vasodilators in impotent patients with hypercholesterolemia or hypertriglyceridemia; 4) involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits; 5) effects of isolated lipoproteins and triglyceride, combined oxidized LDL plus triglyceride, and combined oxidized LDL plus HDL on contractile and relaxation response of rabbit cavernous smooth muscles; 6) involvement of e-NOS in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit. Hypercholesterolemia may cause impairment of endothelium-dependent relaxation. Oxidized LDL is the  major causative cholesterol of the impaired relaxation response. Achain reaction, the production of superoxide radicals and functional impairment of eNOS may be a major cause of the functional impairment in the early stages of hypercholesterolemia.

1 Introduction

Hyperlipidemia has been considered one of the main risk factors of cardiovascular diseases and vasculogenic erectile dysfunction as well. Among the lipid fractions, hypercholesterolemia has been known to be the greatest risk. The level of blood cholesterol is now on the rise in Asia because of the increasing adoption of a western diet, thus, hypercholesterolemia has recently aroused a lot of public attention in this area (Table 1).

Table 1. Changes of mean level of total cholesterol in blood of normal Korean adults.

Year

Level (mg/dL)

1970

154

1981

175

1991

188

1992

193

1999

200

Lipoproteins are macromolecular complexes that carry plasma lipids, particularly cholesterol and triglyceride (TG). Among the lipoproteins, high density lipoprotein (HDL) protects against atherosclerosis, whereas low density lipoprotein (LDL) which is the major carrier of cholesterol in the blood, is known to be of primary importance in the development of coronary atherosclerosis. In 1990, Juenemann et al[1] reported a marked increase of LDL and a decrease of HDL fractions in patients with vasculogenic impotence as compared to those with non-vasculogenic erectile dysfunction. In 1994, Massachusetts Male Aging Study Group[2] reported that the probability of complete impotence was 0% in the older men with HDL values more than 90 mg/dL, whereas the probability increased to 7.2% and 16.1%, respectively when the HDL values dropped to 60 or 30 mg/dL. They added to the finding that total serum cholesterol was not correlated with impotence probability, which support HDL levels as a strong determinant of impotence.

TG has less certain association with coronary heart disease compared to the LDL-cholesterol. Elevations in plasma TG are usually associated with increased synthesis and secretion of very low density lipoprotein (VLDL) which is the major carrier of TG in blood. VLDL does not cause atherosclerosis directly, however, VLDL is partially converted to LDL. The effects of TG on the contractile and relaxation response of vascular smooth muscles have not been established to date. Impaired relaxation response to acetylcholine was demonstrated in hypertriglyceridemic humans with normal levels of plasma LDL-cholesterol, although contrary findings were also reported[3,4].

Thus, we have done consecutive studies to investigate the effects of impaired lipid metabolism on the contractile and relaxation response of cavernous smooth muscles and to elucidate its pathogenesis.
2 Incidence of hyperlipidemia in impotent patients[5]

The incidence of hyperlipidemia was investigated in men aged over 40 years with erectile dysfunction. Blood levels of the various lipid fractions were measured in 943 patients with erectile dysfunction and 242 normal men (Table 2).  

Table 2. Incidence of abnormally high or low blood level of lipid fractions in impotent patients and normal men, 40-70 years old. bP<0.05, cP<0.01 vs control.

Lipid fraction

Normal values
(mg/dL)

Patients (%) 
(n=943)

Control (%)
(n=242)

Total cholesterol

<240

11312.0

249.9

LDL

<150

30632.4c

104.1

HDL

>25

343.6

93.7

Triglyceride

<210

23124.5

5221.5

Hyperlipidemia

 

47250.1b

6526.9

The incidence of abnormally high level of LDL was significantly higher in the patients than in the control men, but there was no significant difference in the incidence of abnormally high blood level of total cholesterol or triglyceride and abnormally low blood level of HDL between the two groups. When hyperlipidemia was defined as abnormally high blood level of more than one lipid fraction, the incidence of hyperlipidemia was significantly higher in  the patients with erectile dysfunction than in the normal control. This result suggests that LDL is the most important lipid fraction related with the erectile dysfunction. Manning et al[6] found a correlation between high LDL and organic erectile dysfunction (68.6% vs 32.4% in the psychogenic impotence group) and a clear positive correlation between high LDL and caverno-venous insufficiency was determined.

3 Erection response to intracavernous injection of papaverine in impotent patients with hyperlipidemia[7]

The erectile response to intracavernous injection of papaverine (30-45 mg) was compared between impotent patients with hyperlipidemia and those with normal blood level of each lipid fraction. Total of 278 patients over 40 years old were enrolled for this study. There was no significant difference in erectile response between the two groups. Papaverine is endothelium-independent, direct smooth muscle relaxant. Therefore, no significant difference in the erectile response to papaverine between patients with hyperlipidemia and those with normal blood level suggests that the hyperlipidemia-induced erectile dysfunction may be related with impairment of endothelium-dependent relaxation.

4 Relaxation responses of isolated cavernosal smooth muscles to endothelium-dependent and endothelium-independent vasodilators in impotent patients with hypercholesterolemia or hypertriglyceridemia[8]

To investigate the relaxation response of the cavernous smooth muscle to endothelium-dependent and endothelium-independent vasoactive agents, cavernous strips taken from the impotent patients with hypercholesterolemia (n=5) or hypertriglyceridemia (n=6) during penile prosthetic surgeries were placed in organ chamber and isometric tension study was conducted. There was no difference in contractile response induced by various concentrations of  norepinephrine (10-9 to 10-4 mol/L) between the impotent patients with or without hypercholesterolemia or hypertriglyceridemia.

The relaxation responses of the tissues taken from the patients with hypercholesterolemia to endothelium-dependnent vasoactive agents, acetylcholine (10-9-10-4 mol/L), adenosine (10-9-10-4 mol/L), and high dose bradykinin (10-6-10-5 mol/L) were significantly reduced, as compared to those from the patients with normal blood level of the total cholesterol (n=16). On the other hand, there was no significant difference in the relaxation responses of the tissues to the endothelium-independent vasodilator, papaverine (10-6-10-5 mol/L) and verapamil (10-6-10-5 mol/L) between the two groups.

The relaxation responses of the tissues taken from the impotent patients with hypertriglyceridemia, both to the endothelium-dependent and endothelium-independent vasodilators  were not significantly different from the patients with normal blood level of triglyceride.

5 Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit[9]

It was reported that endothelial and smooth muscle cells, neutrophils and monocytes or platelets might be a source of oxygen free radical, which were known to interact with polyunsaturated fatty acids of biological membrane, thus leading to lipid peroxidation[10]. Oxygen free radicals such as superoxide radical (O2- ), hydrogen peroxide (H2O2), hydroxyl radical (OH) and singlet oxygen (1O2) are generated by a partial reduction of oxygen during the biological processes[11]. Among the free radical species, superoxide radical had the main role of causing oxygen toxicities. The first line of defense against free radicals is SOD, which scavenges the superoxide radical. The next line of defense are the glutathione peroxidases and catalases. It was reported that SOD activities were generally increased in accordance with the activity of superoxide radical, but little information was reported about the changes in catalase and glutathione peroxidase activity.

Henriksson et al[12] found evidence of a generation of free radicals in hyperlipidemia and atherosclerosis, and relationships between  the free radicals and scavengers, SOD  and catalase. The SOD increased in atherosclerotic aorta by feeding a high cholesterol diet. Gryglewski et al[13] reported that the superoxide radicals contributed significantly to the destruction of the EDRF, and that the EDRF was protected from breakdown by SOD and Ca2+, but not by catalase. Del Boccio et al[14] reported that the changes in aortic antioxidant defense mechanisms and lipid peroxidation precede the massive vascular lipid infiltration in cholesterol-fed rabbits. And some antioxidant mechanisms were increased (SOD, glutathione peroxidase and total thiol compounds), whereas others were depressed (catalase, glutathione reductase and glutathione transferase), thus potentially reducing or increasing vascular susceptibility to oxidative injury.

In our study, the production of superoxide radicals and the activities of total SOD, Mn-SOD and Cu, Zn-SOD increased significantly in the hypercholesterolemic group compared with the control group. The activities of catalase and glutathione peroxidase also increased in the hypercholesterolemic group, but were not significantly higher than in the control group. This suggests that production of the superoxide radicals in cavernous tissues increases in the state of hypercholesterolemia, which leads to functional impairment of cavernous smooth muscle relaxation in response to endotheliummediated stimuli. SOD seems to play a major role as a scavenger against the superoxide radical in cavernous tissue.

6 Effects of isolated lipoproteins and TG, combined oxidized LDL plus TG, and combined oxidized LDL plus HDL on contractile and relaxation response of rabbit  cavernous smooth muscles[15]

LDL is oxidized by oxygen free radicals from the arterial endothelium and the smooth muscle cells, and the oxidized LDL is toxic to endothelia. LDL peroxidation participates in early stages of the atherosclerosis, and injuries of the endothelial cells have principal role in progression of the atherosclerosis. Recent studies showed that oxidized LDL inhibited endothelium-dependent relaxation and enhanced contraction of the vascular smooth muscle[16, 17]. Although controversial, native LDL also might cause alterations in vasoactivity. 

The effects of TG, not to speak of the synergistic effects of combined TG and LDL on contractile and relaxation response of vascular and cavernous smooth muscles have not been established to date. Impaired relaxation response to acetylcholine was demonstrated in hypertriglyceridemic humans with normal levels of plasma LDL-cholesterol, although contrary findings were also reported[3,4].

We investigated the effects of isolated lipoproteins and TG, and the effects of combined oxidized lipoproteins plus TG and the combined LDL plus HDL on the contractility and relaxation responses of rabbit cavernous smooth muscle. Cavernous muscle strips taken from 40 male New Zealand White rabbits (2.5-3.0 kg; n=40) were studied in organ chambers for isometric tension measurement. The strips were exposed to HDL (50 g/mL) , LDL (50 g/mL), oxidized LDL (50 g/mL), TG (short-, medium-, and long-chain; 2.5 mg/mL), and combined oxidized LDL plus TG and combined oxidized LDL plus HDL for 30 min. The oxidized LDL was obtained by exposure of LDL to copper ion for 24 hours at room temperature.

Both HDL and LDL did not affect contraction and relaxation responses of the cavernous muscles. The oxidized LDL did not affect norepinephrine (10-9-10-4 mol/L) induced contractility of the strips, but significantly (P<0.05) decreased the relaxation response of the cavernous strips precontracted with norepinephrine (10-4 mol/L) to endothelium-dependent agonist, acetylcholine (ACh, 10-9- 10-4 mol/L) (Figure 1). The relaxation responses to endothelium-independent vasodilator, sodium nitroprusside (SNP) were not changed after treatment with the oxidized LDL (Figure 1). Nonspecific NO synthase inhibitor (L-NAME) completely inhibited the relaxation response to ACh, and L-arginine partially improved the diminished relaxation, which suggests that the oxidized LDL may inhibit endothelium-dependent, NO-mediated relaxation.

Figure 1. Effect of oxidized LDL on relaxation response of rabbit cavernous smooth muscle. Acetylcholine-induced relaxation was significantly (P<0.05) impaired in oxidized LDL-treated muscles, whereas sodium nitroprusside-induced relaxation was not.

TG significantly (P<0.05) decreased the contractile response of cavernous muscle to NE, regardless of the type of TG, compared to the control group. Short-chain TG attenuated norepinephrine-induced contraction by 60%, medium-chain by 45%, and long-chain by 73%. No significant change of the relaxation responses to both endothelium-dependent and endothelium-independent vasodilators was noted in the short, medium or long chain TG-treated strips, although only the relaxation response to high dose SNP was significantly (P<0.05) decreased in the short-chain TG groups.

We could not find any significant synergistic nor detoxication effects of the oxidized LDL or HDL on the contraction and relaxation responses when they were added to TG.

7 Involvement of e-NOS in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit[18]

It has been suggested that the impairment of endothelium-dependent relaxation in hypercholesterolemia and atherosclerosis might be due to impaired ability to synthesize or release NO, which is an endothelium-derived factor[19]. Kanazawa et al[20] reported that the mechanism of impaired endothelium-dependent relaxation in atherosclerotic aorta of hypercholesterolemic rabbits was not due to the down-regulation of eNOS mRNA and protein. However, functional activities of eNOS could be altered even though the expression of eNOS mRNA and protein was maintained. So, we designed a study to evaluate whether functional impairment and/or protein expression of cNOS was involved in the impairment of endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits.

Sixty male New Zealand White rabbits were randomly divided into control and experimental groups. The control group (n=20) received a regular diet, while the two experimental groups (n=20 for each) were fed a 2% cholesterol diet for 4 and 8 weeks, respectively. We conducted isometric tension studies with endothelium-dependent and endothelium-independent vasodilators with or without preinocculation with L-arginine and NANC-selective electrical field stimulation on isolated strips of corpus cavernosum. Expression of cNOS protein was assessed by Western blot analysis. cNOS activities in both cytosolic and particulate fractions were measured by determining the conversion of L-arginine to L-citrulline.

Blood levels of cholesterol were 28-fold higher (P<0.01) in the experimental groups than in the control group. The relaxation responses to endothelium-dependent agents (acetylcholine, adenosine 5-diphosphate) were significantly reduced (P<0.05) in both experimental groups, regardless of their incubation with L-arginine, compared with the control group. However, no differences were found among the three groups in the relaxation response to endothelium-independent agents (papaverine and nitroprusside) and to NANC-selective electrical field stimulation.

It has been reported that nNOS is principally localized to cytosolic fractions,  whereas eNOS is localized to the membrane fractions[21, 22].  It is difficult to divide cNOS activity measured by citrulline formation assay into eNOS activity and nNOS activity. To overcome this difficulty, we measured cNOS activity in the cytosolic and particulate fractions, respectively. We found that cNOS activity was 3.4-fold higher in the particulate fractions than in the cytosolic fractions in the control rabbit. The particulate cNOS activity was significantly (P<0.05) decreased in the experimental groups, while the cytosolic cNOS activity in the experimental groups was not different from the control group. There has been no available eNOS antibody for detection of eNOS protein in rabbit cavernous smooth muscle, and molecular cloning and sequencing of the eNOS gene in the rabbit have not yet been completely established. In our study using positive control of human endothelial cell for eNOS, the eNOS gene was not detected in particulate and cytosolic fractions of the experimental and control rabbits as well. However, levels of nNOS protein in the particulate fraction were markedly lower. Summarizing the results, the functional impairment of eNOS, rather than nNOS, may lead to impairment of cavernous smooth muscle relaxation in response to endothelium-mediated stimuli in early stage of hypercholesterolemia.

References

[1] Juenemann KP, Muth S, Rohr G, Siegsmund M, Alken P. Does lipid metabolism influence the pathogenesis of vascular impotence? Int J Impotence Res (suppl 2) 1990; 2: 33.
[2] Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol  1994; 151: 54-61.
[3] Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter JM. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am College Cardiol 1997; 29: 964-8.
[4] Lewis TV, Dart AM, Chin-Dusting JP. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma  LDL cholesterol. J Am College Cardiol 1999; 33: 805-12.
[5] Seo KK, Lee SW, Kim SC. Incidence of vascular risk factors in patients with erectile dysfunction aged over 40 years: comparison with normal men of corresponding age. Kor J Androl 1999; 17: 1-16.
[6] Manning M, Schmidt P, Juenemann KP, Alken P. The role of blood lipids in erectile failure. Int J Impotence Res 1996; 8: 167 (D179).
[7] Ko YT, Kim SC. Hyperlipidemia and erection response to intracorporeal injection of papaverine. Kor J Urol 1994; 35: 1113-21.
[8] Kim SC, Kim IK, Lee MY, Uhm DY. Relaxation responses of cavernous smooth muscles to vasodilators in impotent patients with hypercholesterolemia or hypertriglyceridemia. Kor J Androl 1995; 13: 95-101.
[9] Kim SC, Kim IK, Seo KK, Baek KJ, Lee MY. Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits. Urol Res 1997; 25: 341-6.
[10] Steinberg D, Parthasaraty S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
[11] Fridovich I. Superoxide dismutase. Ann Rev Biochem 1975; 44: 147-159.
[12] Henriksson P, Bergstrom K, Edhag O. Experimental atherosclerosis and a possible generation of free radicals. Thrombosis Res 1985; 38: 195-8.
[13] Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-6.
[14] Del Boccio G, Lapenna D, Porreca E, Pennelli A, Savini F, Feliciani P, et al. Aortic  antioxidant defense mechanisms: timerelated changes in cholesterol-fed rabbits. Atherosclerosis 1990; 81: 127-35.
[15] Kim SC, Seo KK, Kim HW, Lee MY. The effects of isolated lipoproteins and triglyceride, combined oxidized LDL plus triglyceride, and combined oxidized LDL plus HDL on the contractile and relaxation response of rabbit cavernous smooth muscle. Int J Androl 2000; 23 (suppl 2): 26-9.
[16] Ahn TY, GomezCoronado D, Martinez V, Cuevas P, Goldstein I, Saenz de Tejada I.  Enhanced contractility of rabbit corpus cavernosum smooth muscle by oxidized low density lipoproteins. Int J Impotence Res 1999; 11: 9-14.
[17] Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990; 86: 75-9.
[18] Seo KK, Yun HY, Kim H, Kim SC. Involvement of endothelial nitric oxide synthase in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit. J Androl 1999; 20: 298-306.
[19] Sreeharan N, Jayakody RL, Senaratne MPJ, Thomson ABR, Kappagoda CT. Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta. Can J Physiol Pharmacol 1986; 64: 1451-3.
[20] Kanazawa K, Kawashima S, Mikami S, Miwa Y, Hirata K, Suematsu M, et al. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol 1996; 148: 1949-56.
[21] Fostermann U, Pollock JS, Schmidt HHHW, Mitchell JA, Kohlhaas KL, Heller M, et al. Characterization and purification of particulate EDRF synthase from bovine aortic endothelial cells. FASEB J 1991; 5: A1728.

[22] Schmidt HHHW, Pollock JS, Nakane M, Gorsky LD, Fostermann U, Murad F. Purifi
cation of a soluble isoform of guanylyl cyclase-activating factor synthase. Proc Natl Acad Sci USA 1991; 88: 365-9.

home

Correspondence to: Prof. Sae-Chul Kim, M.D.,Ph.D. Department of Urology, College of Medicine, Chung-Ang University,65-207, Hangang-Ro 3-Ka, Yongsan-Ku, Seoul 140-757, Korea
Fax: 82-2-792 8496  
e-mail: saeckim@unitel.co.kr
Received 2000-06-14      Accepted 2000-06-22